Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life.
    Benzinga,  Biotechnology,  Health,  Nature,  Regenerative Medicine

    Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    June 15, 2022 /

    Originally Published on Benzinga Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. Cardiologist Dr. Joshua Hare is one of those scientists, and he’s both the co-founder and chief scientific officer of Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. He’s also credited with helping to pioneer the use of stem cells as medicine for the human heart and regularly explores a future where regenerative medicine can prolong human life. The global regenerative medicine market  is estimated to reach $6.49 billion in 2027, up 9.3% from $3.05 billion in 2019. …

    read more
    Jessica N. Abraham Comments Off on Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It

    You May Also Like

    All Electric Race Series, Ferrari, Tesla, Worksport, Terravis Energy, Polaris, KULR, Greenland Technologies, KULR, Phoenix Startups, Arizona Startups, StartEngine Startups, Battle Approved Motors, The Battle Ground, BAM, Chris James, Racing, Electric Vehicles, EVs, UTVs, Utility Terrain Vehicles, ATVs, All Terrain Vehicles, Glamping, Racing, NASCAR,

    What is a UTV, and Why Might Investing in BAM be a Good Idea?

    July 22, 2021
    Battery management systems, battery technologies, battery safety, kulr, benzinga

    NASA-Approved Technologies Essential to Creating Cooler, Lighter and Safer Batteries for EV, Aeronautics and Smart Device Technologies

    July 8, 2021
    Bolawrap from Wrap Technologies is capable of replacing tazer guns, deadly force and police brutality. It's VR training and simulation is just what the streets need when protecting the innocent.

    Investing in a Solution Means Supporting Change, Contributing to a Better Tomorrow (BolaWrap)

    August 30, 2021
  • What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?
    Business,  Benzinga,  Biotechnology,  Finance,  Health

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) — the company formerly known as Cytocom (NASDAQ: CBLI) — recently uplisted to the Nasdaq in lieu of earlier acquisitions involving Cleveland BioLabs and ImQuest Life Sciences, Inc. Last week, the company provided an update on its integration of ImQuest and its plans going forward.  According to Statera, preclinical testing is underway in the screening of second-generation immune therapies using the ImQuest platform for the rapid and accurate assessment of various diseases and how the overall makeup and composition of these diseases interact. The company will look more closely…

    read more
    Jessica N. Abraham Comments Off on What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    You May Also Like

    DISC Insights, DISC Personality, Personality Type, Corporate Culture, Employee Relations, Persona, Behavioral Analysis, Coaching, Dominance, Influence, Hiring Cycles, Recruitment, Talent Acquisition, Onboarding Team Building, Leadership, Workforce Optimization, Corporate Development,

    Coaching life changes for the active personality styles

    April 24, 2019
    The Vault, Examiner, Brand Awareness, Brand Persona, Personality Type, Brand Identity, BrandYou, Competition, Consultant, Doing Business As, Internet Marketing, Web Presence, Digital Marketing, Mobile Marketing, Omnichannel Marketing, Social Branding, Niche Markets, Professionalism, Globalization, Quality Assurance, Subject Matter Expert, Word of Mouth, Referral, Profinder, Social Media, Social Networking, Connections, Brand Loyalty, Brand Integrity,

    Let’s Talk Quality: YOU are Responsible for YOUR Name!

    June 1, 2013
    VoIP, Partners, SMB Solutions, call center, certification, voip services, voip equipment, Media Processing, hardware, middleware, opensource, SIP, SBC, Wireless, ims, Triple Play, Switching, VoIP Peering, regulation

    Could Phishing Expeditions Stop Cold with Deeper Insight?

    March 2, 2016
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.